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Abstract
Administration of N-carbamylglutamate (NCG), an analogue of endogenous N-acetyl-glutamate (an activator of arginine
synthesis) has been shown to enhance neonatal growth by increasing circulating arginine levels. However, the effect of NCG
on pregnancy remains unknown. This study examined the effects of NCG on pregnancy outcome and evaluated potential
mechanisms involved. Reproductive performance, embryo implantation, and concentration of amino acids in serum and
uterine flushing, were determined in rats fed control or NCG supplemented diets. Ishikawa cells and JAR cells were used to
examine the mechanism by which NCG affects embryo implantation. Dietary NCG supplementation increased serum levels
of arginine, onithine, and proline, as well as uterine levels of arginine, glutamine, glutamate, and proline. Additionally, it
stimulated LIF expression, and enhanced the activation of signal transduction and activator of transcription 3 (Stat3), protein
kinase B (PKB), and 70-kDa ribosomal protein S6 kinase (S6K1) during the periimplantation period, resulting in an increase in
litter size but not birth weight. In uterine Ishikawa cells, LIF expression was also enhanced by treatment with arginine and its
metabolites. In trophoblast JAR cells, treatment with arginine and its metabolites enhanced Stat3, PKB, and S6K1 activation
and facilitated cellular adhesion activity. These effects were abolished by pretreatment with inhibitors of phosphatidy-
linositol 3-kinase (wortmannin) and mammalian target of rapamycin (rapamycin). The results demonstrate that NCG
supplementation enhances pregnancy outcome and have important implications for the pregnancy outcome of
mammalian species.
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Introduction
With unprecedented changes in economic and social develop-
ment as well as advanced maternal age, low fertility rate has
become a global concern [1,2]. Early pregnancy loss is a common
complication in human gestation [3] and reduced fertility in farm
animals is of critical importance for efficient animal production
[4]. The embryo implantation process is a key step in reproduction
[5]. Embryonic loss of up to 50% occurs primarily during the pre-
implantation or peri-implantation period for most mammals [6,7].
Among the many factors that are involved in this process [8],
leukemia inhibitory factor antibody (LIF) plays an essential role
[9]. One of the initial events during embryo implantation is the
adhesion of trophoblast cells to glycoproteins in the extracellular
matrix of the uterine epithelium, such as fibronectin, vitronectin,
and laminin [10]. LIF has been shown to promote extravillous
trophoblast adhesion to fibronectin, vitronectin, and laminin
during the first trimester in human pregnancy [11]. Stat3 is
essential for embryo implantation, which can be activated by LIF
[12].
Arginine has a great impact on embryonic/fetal survival,
growth and development [13]. Dietary arginine supplementation
can prevent fetal growth restriction in humans and rats [14,15],
increase the number of live-born piglets in sows/gilts [16,17], and
improve embryo implantation in rats [18]. N-carbamylglutamate
(NCG), a structural analogue of N-acetylglutamate, which
activates a key enzyme (carbamylphosphate synthetase-1) of the
arginine-synthetic pathway [19], is used clinically in the treatment
of N-acetylglutamate synthase deficiency, organic acidurias, and
maple syrup urine disease [20–22]. NCG administration has been
shown to stimulate citrulline and arginine synthesis in enterocytes
[19] and increase endogenous synthesis of arginine, plasma
concentrations of arginine and somatotropin, growth rate, and
muscle protein synthesis in sow-reared piglets [19,23]. Further-
more, dietary NCG supplementation can increase intestinal
growth and heat shock protein-70 expression in weanling pigs
[24]. At present, little is known about the effects of NCG on
pregnancy. We hypothesized that dietary NCG supplementation
during pregnancy can stimulate endogenous synthesis of arginine
and increase the levels of arginine and its metabolites in serum and
uterine fluids, thereby improving reproductive performance. The
objective of the present study was to test this hypothesis in
gestating rats, in Ishikawa and JAR cells to identify the mechanism
involved.
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Results
Reproductive performance of rats fed NCG-
supplemented diet
Dietary NCG supplementation increased litter size, live-born
pup number, litter birth weight, and litter birth weight of live-born
rats, compared with the control group (P,0.001) (Table 1). There
were no differences in birth weight or the ratio of female:male rat
pups among groups (Table 1). In comparison with 0.05% NCG
supplementation, 0.1% NCG supplementation further increased
litter size, live-born pup number, litter birth weight, and litter birth
weight of live-born rats (P,0.001, Table 1).
Amino acid concentrations in maternal serum and
uterine flushings of rats fed a NCG-supplemented diet
Serum concentrations of proline, ornithine, and arginine were
increased in NCG-supplemented rats, compared with controls
(P,0.05, Table 2). No changes in circulating levels of other amino
acids were observed among the treatment groups (Information S1).
The concentrations of proline, arginine, glutamate, and
glutamine in uterine flushings of rats fed the NCG-supplemented
diet were higher than in rats fed the control diet (P,0.05, Table 3).
In contrast, urea concentration tended to decrease (P,0.07) in the
NCG compared with the control group. Concentrations of other
amino acids in uterine flushings did not differ among the treatment
groups (Information S1).
Intrauterine injection of LIF antibody, wortmannin, or
rapamycin during pregnancy in rats fed a NCG-
supplemented diet
Because LIF may be a novel factor mediating the beneficial
action of NCG on pregnancy outcome, we determined the effects
of LIF antibody on the location of embryo implantation sites on d
7 of pregnancy, as well as the number of viable fetuses, weights of
conceptuses, fetuses, and placentas on d 15 of pregnancy in rats
fed the control or NCG-supplemented diet. In rats fed the control
diet, the implantation sites were well distributed in the control
uterine horn on d 7 of pregnancy, but were crowded in rats
receiving administration of the LIF antibody into the uterine horn
(Fig. 1A). However, in rats fed the NCG supplemented diet, the
implantation sites were well spaced both in the control and the LIF
antibody-treated uterine horn (Fig. 1A). On d 15 of pregnancy,
obvious embryo resorption was observed in the uterine horn of
rats receiving the LIF antibody but not in rats fed the NCG-
supplemented diet (Fig. 1B).
Table 1. Reproductive performance of primiparous rats fed NCG supplemented or control diets during pregnancy*.
Items Control 0.05% NCG 0.1% NCG SEM P value
N 96 96 96
Litter size 11.660.23a 12.460.23b 13.160.15c 0.21 ,0.001
Live-born rats, n/litter 11.460.23a 12.260.23b 13.060.15c 0.21 ,0.001
Litter weight, g 73.261.44a 78.261.20b 83.361.09c 1.25 ,0.001
Litter birth weight of
live-born rats, g
72.661.42a 77.561.18b 82.861.16c 1.24 ,0.001
Birth weight, g 6.3460.03a 6.3560.03a 6.3460.02a 0.03 0.92
Birth weight of live-born
rats, g
6.3860.03a 6.3760.03a 6.3660.02a 0.03 0.85
Female/male 1.0960.05a 1.0760.06a 1.0760.07a 0.07 0.97
*Data are means 6 SEM. Means in a row without a common letter differ, P,0.05.
doi:10.1371/journal.pone.0041192.t001
Table 2. Serum concentrations of amino acids in pregnant
rats fed NCG-supplemented or control diets1.
Treatment
Amino acids Control (mmol/L) 0.1% NCG (mmol/L) P value
N 15 15
Proline 181.2612.8 218.168.7* 0.03
Ornithine 101.5615.8 172.2621.0* 0.01
Arginine 130.8618.2 195.1616.8* 0.01
Glutamate 206.0616.5 250.9627.5 0.17
Glutamine 417.1626.4 447.4633.7 0.48
Ammonia 335.9629.7 279.7614.2 0.11
Urea 634.3625.2 584.5636.0 0.27
1Data are means 6 SEM.
*P,0.05: Different from the control group.
doi:10.1371/journal.pone.0041192.t002
Table 3. Amino acid concentrations in uterine flushings of
pregnant rats fed NCG-supplemented or control diets1.
Treatment
Amino acids Control (mmol/L) 0.1% NCG (mmol/L) P value
N 15 15
Proline 21.662.91 51.768.11* 0.003
Ornithine 1.4860.25 1.5760.27 0.86
Arginine 3.0960.19 3.6760.14* 0.03
Glutamate 36.663.9 49.168.30* 0.03
Glutamine 22.662.13 33.864.33* 0.03
Ammonia 29.962.16 32.963.14 0.25
Urea 26.062.66 18.761.48 0.07
1Data are means 6 SEM.
*P,0.05: Different from the control group.
doi:10.1371/journal.pone.0041192.t003
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The number of live fetuses on d 15 of pregnancy was
comparable in the right uterine horns without administration of
the LIF antibody between the control group and NCG group
(Fig. 2A). However, the number of live fetuses was lower in the LIF
antibody-treated uterine horns in rats fed the control diet,
compared with rats fed the NCG-supplemented diet (P,0.05,
Fig. 2A). No differences in weights of conceptuses (Fig. 2B), fetuses
(Fig. 2C), and placentas (Fig. 2D) on d 15 of pregnancy were
detected between the control and NCG groups, or between the
LIF antibody-treated and non-treated uterine horns.
Intrauterine administration of wortmannin, the inhibitor of
phosphatidylinositol 3-kinase (PI3K), completely inhibited embryo
implantation in rats fed the control or the NCG-supplemented diet
(Fig. 1C). A similar response was observed in rats fed the control
diet which received intrauterine administration of rapamycin, the
inhibitor of mammalian target of rapamycin (mTOR) (Fig. 1D).
However, in rats fed the NCG-supplemented diet, embryo
implantation was not totally inhibited, although the number of
implanted embryos was reduced (Fig. 1D).
Uterine expression of LIF and phosphorylated protein
kinase B (p-PKB), phosphorylated 70-kDa ribosomal
protein S6 kinase (p-S6K1), and phosphorylated signal
transduction and activator of transcription 3 (p-Stat3) in
rats fed a NCG-supplemented diet
Dietary NCG supplementation increased (P,0.05) uterine
expression of LIF, p-Stat3, p-PKB, and p-S6K1 by 1.32-fold,
1.56-fold, 1.12-fold, and 3.30-fold, respectively, compared with the
control group on day 5 of pregnancy (Fig. 3, Information S2). In
response to intrauterine administration of the LIF antibody on day
4 of pregnancy, the expression of LIF and p-PKB, p-S6K1, and p-
Stat3 was also increased (P,0.05) by 1.64-fold, 0.96-fold, 1.67-
fold, and 0.43-fold in NCG group on d 7 of pregnancy, compared
with controls (Fig. 3, Information S2).
In the control group, intrauterine administration of wortmannin
markedly attenuated the expression of uterine LIF and p-S6K1.
The expression of Stat3 appeared to be undetectable whereas p-
PKB was detectable but significantly decreased. In the NCG
group, the expression of LIF, p-PKB, p-S6K1, and p-Stat3 was
enhanced in the uterus (Fig. 3, Information S2). In response to
intrauterine administration of rapamycin, the expression of LIF, p-
S6K1, and p-Stat3 in the uterus of the control group was weak.
Figure 1. Embryo implantation in the presence of LIF antibody,
wortmannin or rapamycin. Embryo implantation in the presence of
LIF antibody on d 7 (A) and d 15 (B) of pregnancy, wortmannin on d 7 of
pregnancy (C), or rapamycin on d 7 of pregnancy (D) in rats fed a 0.1%
NCG-supplemented or control diets. Ab= antibody, Wort =wortmannin,
Rapa= rapamycin.
doi:10.1371/journal.pone.0041192.g001
Figure 2. Live fetus counts and the weight of conceptuses,
fetuses, and placentas of rats with or without intrauterine
injection of LIF antibody. Live fetus counts (A), weight of
conceptuses (B), fetuses (C), and placentas (D) on d 15 of pregnancy
in the presence and absence of LIF antibody in rats fed 0.1% NCG-
supplemented or control diets. Data were given as means 6 SEM, n= 6.
Means with different letters were significant (P,0.05). Ab= antibody.
doi:10.1371/journal.pone.0041192.g002
Figure 3. The relative protein abundance of uterine p-Stat3,
LIF, p-S6K1, and p-PKB. The relative protein abundance of uterine p-
Stat3, LIF, p-S6K1, and p-PKB in rats fed a NCG-supplemented or control
diet on d 5 (A), and d 7 of pregnancy in the presence of LIF antibody (B),
and on d 7 in the presence of wortmannin (C) and rapamycin (D).
Con =Control, Ab = antibody, Wort =wortmannin, Rapa = rapamycin.
*means significance in comparison with the control.
doi:10.1371/journal.pone.0041192.g003
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However, in the NCG group, the expression of uterine LIF, p-
PKB, p-S6K1, and p-Stat3 was increased (Fig. 3, Information S2).
Expression of p-PKB, p-S6K1, and p-Stat3 in JAR cells in
response to arginine, glutamine, glutamate, and proline
Because the concentrations of arginine, glutamine, glutamate,
and proline in uterine flushing were increased in response to
dietary NCG supplementation, we conducted a series of experi-
ments using JAR cells and Ishikawa cells as in vitro models to
determine the effects of these four amino acids on embryo
implantation. The expression of p-PKB, p-S6K1, and p-Stat3 was
increased (P,0.05) in JAR cells treated with arginine (Information
S2) and glutamine (Information S2) in a dose-dependent manner
(Table 4). Proline (Information S2) also activated the expression of
p-PKB and p-S6K1, but glutamate did not (Table 4, Information
S2). p-Stat3 was not detectable in cells treated with proline and
glutamate. Arginine increased the expression of p-PKB, p-S6K1,
and p-Stat3 within 0.5 h (Table 5, Information S2), whereas
glutamine enhanced expression of these phosphorylated proteins
within 1 h (Table 5, Information S2). Similar results were reported
for proline and glutamate (Table 5, Information S2). Phosphor-
ylated PKB, S6K1, and Stat3 were not detectable in the presence
of wortmannin or rapamycin.
LIF expression in Ishikawa cells in response to arginine,
glutamine, glutamate, and proline in the presence or
absence of LIF antibody
In the absence of LIF antibody, the addition of arginine to the
culture medium did not affect LIF expression in Ishikawa cells
(Table 6, Information S2). However, glutamine (Information S2),
glutamate (Information S2) and proline (Information S2) increased
LIF expression in Ishikawa cells (Table 6, P,0.05). In response to
LIF antibody supplementation, LIF expression in Ishikawa cells
was totally inhibited (Table 7, Information S2). Arginine in the
culture medium did not affect LIF expression in the presence of
LIF antibody (Table 7, Information S2) although glutamine,
glutamate and proline increased LIF expression in the presence of
LIF antibody (Table 7, Information S2). LIF was not detectable
when wortmannin or rapamycin was added to the Ishikawa cell
culture medium.
LIF concentrations in the culture medium of Ishikawa
cells in response to arginine, glutamine, glutamate, and
proline in the presence or absence of LIF antibody
In the absence of LIF antibody, arginine, glutamine, glutamate,
and proline treatment for 16 h dramatically increased LIF
Table 4. Effects of the different dose of amino acids on expression of p-Stat3, p-S6K1, and p-PKB in JAR cells*.
Concentration of amino acids (mM)
Items 0 0.25 0.5 1 2 4 SEM P value
Arginine
p-Stat3/actin 0.05a 0.10b 0.11b 0.14c 0.28d 0.17e 0.002 ,0.01
p-S6K1/actin 0.10a 0.22b 0.16c 0.22b 0.29d 0.26e 0.003 ,0.01
p-PKB/actin 0.11a 0.31b 0.30b 0.23c 0.20d 0.22c 0.005 ,0.01
Glutamine
p-Stat3/actin 0.10a 0.14b 0.17c 0.28d 0.37e 0.24f 0.005 ,0.01
p-S6K1/actin 0.07a 0.25b 0.18c 0.4d 0.27e 0.19c 0.006 ,0.01
p-PKB/actin 0.18a 0.34b 0.51c 0.50d 0.82e 0.71f 0.006 ,0.01
Glutamate
p-S6K1/actin 0.15a 0.15a 0.15a 0.14a 0.15a 0.15a 0.004 0.42
p-PKB/actin 0.16a 0.16a 0.17a 0.17a 0.17a 0.17a 0.004 0.21
Proline
p-S6K1/actin 0.61a 0.74b 0.63a 0.85c 0.88c 0.84c 0.01 ,0.01
p-PKB/actin 0.29a 0.44b 0.44b 0.60c 0.36d 0.30a 0.004 ,0.01
*Values with different letters are significantly different (P,0.05). Values are means 6 SEM, n = 6.
doi:10.1371/journal.pone.0041192.t004
Table 5. Effects of the different time treatments of amino
acids on expression of p-Stat3, p-S6K1, and p-PKB in JAR cells*.
Time of treatment (h)
Items 0 0.5 1 2 4 SEM P value
Arginine
p-Stat3/actin 0.23a 0.77b 0.76b 0.77b 0.48c 0.004 ,0.01
p-S6K1/actin 0.30a 0.32b 0.36c 0.60d 0.65e 0.004 ,0.01
p-PKB/actin 0.10a 0.22b 0.35c 0.25d 0.51e 0.005 ,0.01
Glutamine
p-Stat3/actin 0.14a 0.18b 0.20c 0.38d 0.54e 0.004 ,0.01
p-S6K1/actin 0.11a 0.12a 0.22b 0.25c 0.27d 0.005 ,0.01
p-PKB/actin 0.18a 0.27b 0.29c 0.23d 0.21e 0.003 ,0.01
Glutamate
p-S6K1/actin 0.06a 0.09b 0.08b 0.16c 0.11d 0.004 ,0.01
p-PKB/actin 0.10a 0.12b 0.18c 0.43d 0.33e 0.009 ,0.01
Proline
p-S6K1/actin 0.42a 0.76b 0.95c 0.88d 0.86d 0.004 ,0.01
p-PKB/actin 0.28a 0.60b 0.55c 0.56c 0.49d 0.005 ,0.01
*Values with different letters are significantly different (P,0.05). Values are
means 6 SEM, n = 6.
doi:10.1371/journal.pone.0041192.t005
N-Carbamylglutamate and Pregnancy Outcome
PLoS ONE | www.plosone.org 4 July 2012 | Volume 7 | Issue 7 | e41192
concentration in the culture medium of Ishikawa cells, compared
with the control (P,0.05, Fig. 4A). Among the four amino acids,
the positive effect of arginine was the greatest (Fig. 4A). In the
presence of LIF antibody, LIF concentration was still higher in the
culture medium of Ishikawa cells supplemented with arginine,
glutamine, glutamate, or proline, compared with the control
(P,0.05, Fig. 4B). In addition, arginine treatment resulted in the
greatest positive effect among the four amino acids tested (Fig. 4B).
Adhesion of JAR cells to fibronectin or laminin in
response to arginine, glutamine, glutamate, and proline
The addition of arginine and glutamine to the culture medium
increased the rate of adhesion of JAR cells to fibronectin (Fig. 5A)
and laminin (Fig. 5B), compared with controls (P,0.05). However,
no effect was found for glutamate or proline.
Discussion
In the present study, we reported that dietary NCG supple-
mentation could increase the litter size and the concentration of
arginine family of amino acids in serum and uterine flushings in
rats. Besides, we reported dietary NCG supplementation could
stimulate PKB/mTOR signaling pathway and LIF expression in
rats. Finally, we further confirmed the mechanism in-vitro by
using Ishikawa and JAR cells.
Dietary arginine supplementation has been shown to ameliorate
intrauterine growth restriction in women [13,14] and to increase
litter size in gilts, sows, and rats [16,18]. However, arginine is
supplied with L-arginine-HCl to animals and humans to prevent
acid-base imbalance [25]. With concerns about the effects of
chronic provision of chloride on animal and human health [26], as
well as the short biological half-life cycle of arginine [27],
alternatives should be explored to substitute for arginine. One
choice is L-citrulline [25]. On d 135 of gestation, intravenous
administration of L-citrulline to pregnant ewes is more effective in
increasing concentrations of arginine in both maternal and fetal
circulations, compared with arginine [28]. NCG is a metabolically
stable activator of arginine synthesis [29] and is not toxic to
animals or humans [30,31]. Oral administration of NCG increases
endogenous synthesis of arginine and plasma arginine concentra-
tion and muscle protein synthesis in piglets [19]. However, there
are no reports of the efficacy of NCG supplementation in pregnant
mammals.
In this study, we found that dietary NCG supplementation
increased litter size and litter weight. These effects were associated
with increases in serum concentrations of arginine, ornithine, and
proline and concentrations of arginine, proline, glutamate, and
glutamine in uterine flushings. Amino acids are components of
uterine fluids which are required for the development of early
embryos, and act as precursors of proteins and nucleic acids,
energy sources, and signaling molecules [32]. Previous study
demonstrated that the amounts of arginine and glutamine in
uterine flushings were increased in pregnant ewes during the peri-
implantation period [33]. Amino acids are now known to regulate
embryo development and blastocyst implantation [34]. Mouse and
human embryos express many amino acid transporters to
selectively transport arginine [34], suggesting that arginine is
important for embryogenesis, embryo/fetal survival, growth, and
development, not only for protein synthesis, but also for the
production of its metabolites, such as nitric oxide, polyamines,
creatine, and prolyl residue-rich extracellular matrix proteins that
are important for embryo implantation [35–37]. Glutamine is the
major energy source for developing conceptuses [38]. Glutamate is
important for the synthesis of glutathione, the most abundant
antioxidant in cells [39]. During early pregnancy, total glutathione
in the uterine fluid of pregnant ewes was also increased [33].
Notably, changes of concentrations of glutamine and glutamate in
serum and uterine flushings were not consistent. Although serum
concentrations of glutamine and glutamate were not significantly
increased, compared with the control group, there was an increase
trend. However, the concentrations of these two amino acids in
uterine flushings were significantly higher, in comparision with the
control group. The reason may be the requirement of these two
amino acids for embryo development and implantation resulted in
the differences in metabolism in serum and uterine flushings.
Thus, increases in concentrations of arginine, proline, glutamate,
and glutamine in serum and uterine fluid could supply adequate
nutrients for early embryonic development and implantation.
These data suggest that dietary NCG supplementation has the
potential to improve pregnancy outcomes due to its efficiency in
increasing concentrations of the arginine-family of amino acids in
maternal circulations and uterine fluids, which could improve
early embryonic development and implantation.
Amino acids secreted in the uterine microenvironment are
critical to provide nutrients for mammalian embryo development
and the regulation of embryo implantation [34,37]. LIF is an
important factor in regulating early embryogenesis and embryo
implantation [40,41]. LIF can enhance the quality of human
blastocysts, accelerate embryonic hatching and survival, and
increase adhesion of trophoblast cells to fibronectin and laminin
Table 6. Effects of the different amino acids on expression of
LIF in Ishikawa cells*.
Time of treatment (h)
Items 0 0.5 1 2 4 SEM P value
Arginine 0.10a 0.10a 0.11a 0.10a 0.11a 0.004 0.67
Glutamine 1.02a 1.31b 1.37c 1.26d 1.23e 0.004 ,0.01
Glutamate 0.26a 0.55b 0.81c 0.74d 0.74d 0.004 ,0.01
Proline 0.08a 0.27b 0.30c 0.47d 0.49e 0.003 ,0.01
*Values with different letters are significantly different (P,0.05). Values are
means 6 SEM, n = 6.
doi:10.1371/journal.pone.0041192.t006
Table 7. Effects of the different amino acids on the expression of LIF in Ishikawa cells in the presence of LIF antibody*.
Treatment
Item Control Arginine Glutamine Glutamate Proline SEM P value
LIF/actin 0a 0a 0.33b 0.10c 0.11c 0.002 ,0.01
*Values with different letters are significantly different (P,0.05). Values are means 6 SEM, n = 6.
doi:10.1371/journal.pone.0041192.t007
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[40–42]. Female mice lacking LIF produced viable blastocysts, but
the blastocysts failed to implant [9]. Exposing embryos to LIF has
been shown to improve implantation, pregnancy rate, and viability
[43]. To examine whether the increase in the arginine family of
amino acids induced by dietary NCG supplementation affects
uterine LIF expression, intrauterine administration of LIF
antibody was performed on d 4 of pregnancy. Our results indicate
that LIF antibody treatment resulted in crowding of embryos,
which was reversed by dietary NCG supplementation. In addition,
NCG supplementation partially blocked the decline in the number
of live fetuses on d 15 of pregnancy induced by LIF antibody
treatment. Furthermore, NCG supplementation increased uterine
LIF expression regardless of uterine administration of LIF
antibody. In order to further determine the contributions of
arginine, glutamine, glutamate, and proline (whose concentrations
were increased in uterine flushing by dietary NCG supplementa-
tion) on uterine LIF expression, Ishikawa cells, a human
endometrial epithelial cell line, were used. Although there has
been some difficulty in correlating changes observed in Ishikawa
cells with the actual changes occurring in vivo in the uterus [44],
compared with other cell lines, Ishikawa cell is a good in-vitro
model to study embryo implantation [45]. The results showed that
glutamine, glutamate, and proline enhanced LIF expression in
Ishikawa cells within 4 h and LIF concentration in the culture
medium within 16 h in the presence or absence of LIF antibody.
Although there was a delayed effect of arginine on LIF expression,
this amino acid had the greatest impact on increasing LIF
concentrations in the culture medium within 16 h in the presence
or absence of LIF antibody. As the purpose of the in vitro
experiments is to test the contributions of the four amino acids
which were increased in uterine flushings, to exclude the amino
acids in the Roswell Park Memorial Institute-1640 (RPMI-1640)
culture medium, cells were deprived of amino acids by incubation
in Earle’s balanced salt solution supplemented with a vitamin
mixture. We tried to culture the cells in such medium for 24 hr,
and found that there were lots of cells floating in the medium in
the presence or absence of the four amino acids’ treatment. Also,
the attachment of the cells was not as tight as that in the complete
RPMI-1640 medium. This may be owing to the nutrition
restriction which impaired the cell growth. So finally we decided
to culture the cells for no longer than 24 hr. The results indicate
that the increase in the arginine family of amino acids induced by
dietary NCG supplementation enhanced uterine LIF expression.
To determine the possible signaling pathway mediating the
effect of NCG on uterine LIF expression, inhibitors of PI3K and
mTOR were administered into the uterine horns. PI3K plays
important roles in oocyte maturation, preimplantation embryo
development, embryo survival and pregnancy outcome [46]. This
cellular signaling pathway is also crucial for placental development
as well as differentiation and migration of trophoblast cells [47–
49]. Inhibition of the PI3K/Akt pathway affected the normal
physiology of the blastocyst and delayed blastocyst hatching,
ultimately affecting implantation [49]. In addition, inhibition of
the PI3K pathway led to the induction of apoptosis in both murine
blastocysts and trophoblast stem cells [50]. Inhibition of PI3K
results in increased fetal resorption and poor pregnancy outcome
[50]. In keeping with these reports, we found that uterine
administration of the PI3K inhibitor, wortmannin, almost
completely inhibited embryo implantation, and that dietary
NCG supplementation could not reverse this effect, indicating
that the PI3K signaling pathway is necessary for the action of
NCG.
A key downstream target of PI3K is mTOR [51]. The mTOR
signaling pathway plays a critical role in embryo implantation.
Embryos deficient in mTOR died quickly after implantation
owing to the impaired cell proliferation in both the embryonic and
extra-embryonic compartments, as well as the impaired ability to
form trophoblasts [52,53]. Amino acid signals could regulate the
translation of proteins required for trophoblast differentiation via
mTOR-dependent phosphorylation of S6K1 [54]. Intrauterine
administration of the mTOR inhibitor, rapamycin, on d 4 of
pregnancy decreased implantation sites in mice [55]. Similarly, in
our study, rapamycin treatment inhibited embryo implantation in
pregnant rats fed the control diet but dietary NCG supplemen-
tation attenuated the rapamycin-induced loss of implanted
embryos. These data further support the view that the improve-
ment in pregnancy outcome in NCG-supplemented rats requires
the stimulation of PI3K/Akt/mTOR signaling pathway. In
addition, dietary NCG supplementation increased the expression
of uterine LIF and p-Stat3, as well as p-PKB and p-S6K1, even in
Figure 4. LIF level in medium of Ishikawa cells. LIF concentration
in cultural medium of Ishikawa cells supplemented with L-arginine, L-
glutamine, L-glutamate, or L-proline in the absence (A) or presence of
LIF antibody (B). Data are means 6 SEM (n= 6). Means with different
letters differ (P,0.05). Con, control; Ab, antibody; Arg, arginine; Gln,
glutamine; Glu, glutamate; Pro, proline.
doi:10.1371/journal.pone.0041192.g004
Figure 5. Adhesion rate of JAR cells to fibronectin or laminin.
Adhesion of JAR cells to fibronectin (A) or laminin (B) in response to
arginine, glutamine, glutamate, and proline supplementation. Data are
means 6 SEM (n= 6). Means with different letters differ (P,0.05). Con,
control; Arg, arginine; Gln, glutamine; Glu, glutamate; Pro, proline.
doi:10.1371/journal.pone.0041192.g005
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the presence of LIF antibody. However, the increase in expression
of these genes, except p-Stat3, in the NCG group was weak when
the uterus received administration of inhibitors of PI3K or
mTOR. These findings indicate that the improvement in
reproductive performance brought about by dietary NCG
supplementation is possibly through the PI3K/Akt/mTOR
signaling pathway to stimulate uterine LIF expression. Also there
may be other signaling pathways which mediate the role of NCG
in regulating LIF, such as nitric oxide, polyamines, or mitogen
activated protein kinase (MAPK) pathways, which could be
investigated in the future.
Amino acids regulate the development of trophoblast protrusive
activity, initiation of motility, and the spreading behaviors which are
required for embryo implantation through the mTOR signaling
pathway [37]. Additionally, Stat3 is required for murine embryo
development [56]. To examine the contributions of arginine,
glutamine, glutamate, and proline to the development of tropho-
blasts in vitro, JAR cells, trophoblast-type cells, were used. Results
indicated that arginine and glutamine treatment increased the
expression of p-PKB, p-S6K1, and p-Stat3 in JAR cells. Proline
treatment activated the expression of p-PKB and p-S6K1, but not
Stat3. Thus, among the four amino acids tested, both arginine and
glutamine stimulated PI3K/Akt/mTOR signaling and Stat3
phosphorylation in trophoblast cells, while proline stimulated the
PI3K/Akt/mTOR signaling, but not Stat3 phosphorylation.
Furthermore, rapamycin inhibited amino acid stimulation of
embryo outgrowth, meaning that mTOR is required for the
initiation of protrusive activity in trophoblast cells [54]. In this study,
p-PKB, p-S6K1, and p-Stat3 were not detectable in JAR cells
treated with arginine, glutamine, glutamate, and proline in the
presence of wortmannin or rapamycin. These results indicate that
activation of the PI3K/Akt/mTOR signaling is responsible for
NCG regulation of Stat3 phosphorylation in JAR cells. Embryos
cultured in the amino acid-free mediums could not form trophoblast
cell outgrowths on fibronectin, but could do so when transferred
into the complete medium [53]. Furthermore, there is evidence that
trophoblast invasiveness is connected with Stat3 activity [57]. In this
study, we found that arginine and glutamine, but not proline or
glutamate, increased the adhesion of JAR trophoblast cells to
fibronectin and laminin. The underlying mechanism could be that
arginine and glutamine, but not proline and glutamate, increase the
expression of p-Stat3. These results demonstrate that among the
arginine family of amino acids, both arginine and glutamine may
increase the expression of p-Stat3 and adhesiveness of trophoblast
cell to the extracellular matrix via activation of the PI3K/Akt/
mTOR signaling pathway, which are very important to embryo
implantation.
In conclusion, dietary NCG supplementation is effective in
increasing the pregnancy outcome in rats because of its efficiency
in increasing concentrations of the arginine family of amino acids
in maternal circulations and uterine fluids. These amino acids, in
turn, may activate the PI3K/Akt/mTOR signaling pathway and
Stat3 phosphorylation, stimulate LIF expression, and enhance
trophoblast cell adhesion to the extracellular matrix. Such changes
may be beneficial to successful embryo implantation and
maintenance of pregnancy in mammals. These findings may have
important implications for improving the pregnancy outcome of
mammalian species.
Materials and Methods
Animals and protocols
All rats used in this study were housed and handled according to
the established guidelines of the China Department of Agriculture.
All procedures were approved by the China Agricultural
University Animal Care and Use Committee. The experimental
design is summarized in Information S1.
Adult female Sprague-Dawley rats, weighing 220 g to 250 g,
were purchased from Beijing Laboratory Animal Center and
housed in cages in a temperature (23uC), humidity (relative
humidity, 50%), and light (12 h light/12 h dark) controlled room
with free access to food and water. Pregnancy was produced by
overnight caging of a proestrous female with a fertile male rat.
Next morning, the presence of spermatozoa in the vaginal smear
was defined as d 1 of pregnancy.
The effects of dietary NCG (Sigma) supplementation during the
entire period of pregnancy on pregnancy outcome of rats were
determined. A total of 288 pregnant rats was randomly divided
into the following 3 dietary groups (n = 96 per treatment group): 1)
basal rodent non-purified diet (Science Australia United Efforts
Incorporation) [18]; 2) basal rodent non-purified diet plus 0.05%
(wt:wt) NCG; and 3) basal rodent non-purified diet plus 0.1%
(wt:wt) NCG. At birth, litter size, litter weight, birth weight of
pups, the number of dead pups, and the gender of rats were
determined.
According to the results, we found 0.1% NCG diet has the most
significant effects on the reproductive performance of rats.
Therefore, we designed the following animal experiments only
including the control and 0.1% NCG groups. To determine the
effects of dietary NCG supplementation on the concentrations of
amino acids in serum and uterine fluid during early gestation, 30
pregnant rats were assigned randomly to the basal diet or the basal
diet plus 0.1% (wt:wt) NCG between d 1 and the evening of d 4,
and then food was removed. This dose of NCG was chosen based
on the results of the first animal study. Rats received only water
until 08:00 on d 5, when all rats were anesthetized by an
intraperitoneal injection of sodium pentobarbital (25 mg/kg).
Blood samples were collected from the abdominal aorta and
serum was stored at 220uC until analysis of amino acids. Uterine
flushings were carried out according to the modified methods
described by Bonnamy et al.. Briefly, uterine horns of each
pregnant rat were exposed by laparotomy, dissected free of
connective tissues, clamped at the ends near the cervix. Then
0.9% saline (0.8 mL) was flushed through one horn from the
uterotubal junction and the washing recovered at the cervical end
of the horn then flushed through the other horn. The collected
uterine washing was centrifuged at 3,0006g at 4uC for 15 min and
the supernatant was collected and stored at 220uC until amino
acid analysis. Thereafter, the uteri were frozen in liquid nitrogen
quickly for Western blot analysis.
Administration of LIF antibody, phosphatidylinositol 3-
kinase (PI3K), or mammalian target of rapamycin (mTOR)
inhibitors in vivo
To determine whether the effect of dietary NCG supplemen-
tation on pregnancy outcome in rats was associated with uterine
LIF expression, a series of experiments were conducted by
intrauterine injection of LIF antibody. LIF antibody was used as
a neutralizing antibody to reduce the total amount of available
LIF. Pregnant rats were randomly assigned to either a control or
NCG group (n= 12/treatment group) and underwent midventral
laparotomy after anesthesia on the morning of day 4 of pregnancy.
The fat pad which accompanies ovary and uterus was gently
pulled out from the body cavity. LIF antibody (2 mg diluted in
50 mL 0.9% saline; R&D Systems) was slowly injected into the left
uterine horn of each rat from the cervix toward the uterotubal
junction [58,59]. Each pregnant rat served as their own control,
with the right uterine horn receiving 50 mL 0.9% saline. On d 7 of
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pregnancy, six rats in each group were killed after anesthesia.
Uteri were frozen in liquid nitrogen quickly after the number of
implantation sites was counted in each uterine horn. The
remaining 6 pregnant rats in each group were killed on d 15 of
pregnancy after anesthesia. The weights of conceptuses, fetuses,
placentas, and the number of live fetuses were recorded.
To establish whether the PI3K/protein kinase B (PKB)/mTOR
signaling transduction pathway is involved in the enhancement of
pregnancy outcome by NCG, we investigated the effects of
blocking these signaling molecules by using intrauterine injection
of their inhibitors. Pregnant rats were randomly assigned to either
the control or NCG group. The left uterine horn of all rats
underwent intrauterine injection of 20 ug wortmannin (inhibitor
of PI3K, diluted in 50 mL 0.9% saline; n= 12; Sigma) or 20 ug
rapamycin (inhibitor of mTOR, diluted in 50 mL 0.9% saline;
n = 14; Sigma) on d 4 of pregnancy [60,61]. The right uterine horn
was injected with saline as the control. All rats were killed after
anesthesia on d 7 of pregnancy. Uteri were sampled as above after
the number of implanted embryos was recorded.
Cell culture and treatment
To further examine the contributions of arginine, glutamine,
glutamate, and proline, which were increased in uterine flushings
of rats fed the NCG-supplemented diet, Ishikawa cells and JAR
cells were used as in vitro models. We initially tried to isolate
endometrial cells from pregnant rates (day 3) according to the
procedures reported by Arnold and colleagues [62]. Unfortunate-
ly, the density and purity of the isolated endometrial cells,
harvested from the rat uteri, were not acceptable for subsequent in
vitro experiments. Ishikawa cells (human endometrial epithelial
cell line) and JAR cells (human trophoblastic cell line) were
obtained from European Collection of Cell Culture (ECACC) and
American Type Culture Collection (ATCC) and cultured in
RPMI-1640 (Hyclone) medium supplemented with 10% fetal
bovine serum (FBS). After reaching confluence, cells were deprived
of amino acids by incubation in Earle’s balanced salt solution
(EBSS) (Sigma) supplemented with a vitamin mixture (catalog
No. R7256, Sigma), according to the established protocols [63].
After 3 h, cells were used for the following experiments.
JAR cells were cultured in EBSS medium supplemented with 0,
0.25, 0.5, 1.0, 2.0, and 4.0 mM arginine, glutamine, glutamate, or
proline (Sigma). After 2 h, cells were collected to detect the
expression of p-PKB, p-S6K1, and p-Stat3. The time course (0,
0.5, 1.0 2.0, and 4.0 h) of the change in the expression of p-PKB,
p-S6K1, and p-Stat3 in the presence of 2 mM of either arginine,
glutamine, glutamate, or proline in the culture of JAR cells was
determined. In addition, JAR cells were incubated in EBSS
medium containing wortmannin (10 mM) or rapamycin (20 nM).
After 30 min incubation, phosphate buffered saline (PBS) or
2 mM of arginine, glutamine, glutamate or proline was added to
the medium for each inhibitor treatment. After 2 h, cells were
harvested to detect p-PKB, p-S6K1, and p-Stat3.
Ishikawa cells were cultured in EBSS medium supplemented
with PBS or 2 mM arginine, glutamine, glutamate, or proline.
After 2 h, the expression of LIF in cells was determined.
Additionally, Ishikawa cells were incubated in EBSS medium
containing 2 mg LIF antibody plus PBS or 2 mM arginine,
glutamine, glutamate, or proline. After 2 h, cells were harvested to
detect LIF expression. Ishikawa cells also were incubated in EBSS
medium containing wortmannin (10 mM) or rapamycin (20 nM).
After a 30 min incubation period, PBS or 2 mM of arginine,
glutamine, glutamate or proline for each inhibitor treatment were
added. After 2 h, cells were harvested to detect LIF expression.
Ishikawa cells also were cultured in EBSS medium supplemented
with PBS or 2 mM arginine, glutamine, glutamate or proline, in
the presence or absence of 2 mg LIF antibody. After 16 h, medium
was collected for LIF assay following the manufacturer’s instruc-
tion (R&D Systems).
Cell adhesion assay
To investigate the contributions of arginine, glutamine,
glutamate, and proline on the adhesion of trophoblast cells to
different extra-cellular matrix elements, the adhesion of JAR cells
to fibronectin or laminin was performed in vitro using fibronectin or
laminin-coated CytoMatrix cell adhesion strips (Millipore). Briefly,
cells were starved as indicated above, and then treated with PBS or
2 mM arginine, glutamine, glutamate, or proline for 2 h. After
that, 100 mL of the diluted cell suspension (16106 cells/mL) was
seeded to wells coated with fibronectin or laminin. The plate was
incubated at 37uC for 1 h in a CO2 incubator. Wells were gently
washed 2–3 times with PBS containing Ca2+/Mg2+ (200 mL/well)
followed by addition of 0.2% crystal violet in 10% ethanol and
incubation for 5 min at room temperature. The stain was
removed, and the wells gently washed. Cells were solubilized by
addition of 100 mL of solubilization buffer (a 50/50 mixture of
0.1 M NaH2PO4, pH 4.5 and 50% ethanol). The absorbance was
determined at 570 nm on a microplate reader.
Western blot analysis
Cells or frozen uteri were homogenized in the RIPA lysis buffer
containing protease inhibitor cocktails (Amresco). After 30 min
incubation, homogenates were centrifuged at 14,0006 g for
15 min at 4uC, the supernatant fluid collected, and stored at
280uC. Protein concentrations were determined by using the
BCA protein assay kit (Pierce). Equal amounts of proteins (35 mg
total protein for LIF, p-PKB, p-S6K1, p-Stat3, and b-actin) were
electrophoresed (Bio-Rad) on SDS-polyacrylamide gels. Proteins
were electro-transferred to a PVDF membrane (Millipore) and
blocked with 5% nonfat dry milk at 4uC overnight. Prestained
protein markers (Fermentas) were run in each gel. Samples were
incubated with rabbit anti-rat polyclonal antibodies (1:1000
dilution for 2 h at room temperature or overnight at 4uC) against
LIF, p-PKB (Ser473), p-S6K1 (Thr389), p-Stat3 (Tyr705), or b-
actin (anti-LIF, R&D Systems; anti-p-S6K1, and anti-b-actin,
Santa Cruz; anti-p-PKB, anti-p-Stat3, Cell Signaling Technology).
After being washed with Tris-Tween-20 buffer (pH 7.4), mem-
branes were incubated with the horseradish peroxidase-conjugated
goat anti-rabbit IgG (ZSGB-BIO) for 45 min at room tempera-
ture. The membrane was exposed to the X-ray film for 1 to 6 min.
Band densities were detected with the western blotting luminance
reagent (Santa Cruz) and quantified using AlphaImager 2200
(Alpha Innotech) software.
Statistical analysis
Data of the reproductive performance and cell culture
experiments were subjected to one-way analysis of variance
(ANOVA), followed by Duncan’s Multiple Range test using the
General Linear Model (GLM) procedures of SAS Statistical
Software (Version 9, SAS Institute). Data on amino acids in serum
and uterine flushing were analyzed using the t-test of SAS (version
8.0, SAS Institute). Results are expressed as means 6 SEM.
P,0.05 was considered significant.
Supporting Information
Information S1 Supporting tables. Table S1. Effects of
dietary NCG supplementation on the concentrations of amino
acids in serum. Table S2. Effects of dietary NCG supplementation
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on the concentrations of amino acids in uterine flushings of the
pregnant rats. Table S3. Summary of the experimental designs in
this study.
(DOC)
Information S2 Supporting figures. Figure S1. Expression
of uterine p-Stat3, LIF, p-S6K1, and p-PKB in rats. Rats were fed
a NCG-supplemented or control diet on d 5 (A), and d 7 of
pregnancy in the presence of LIF antibody (B), and on d 7 in the
presence of wortmannin (C) and rapamycin (D). Ab= antibody,
Wort =wortmannin, Rapa= rapamycin. Figure S2. Dose response
and time course for expression of p-Stat3, p-S6K1, and p-PKB in
JAR cells. Cells were supplemented with L-arginine (A, B), L-
glutamine (C, D), L-glutamate (E, F), or L-proline (G, H). Arg,
arginine; Gln, glutamine; Glu, glutamate; Pro, proline. Figure S3.
Expression of LIF in Ishikawa cells. Cells were supplemented with
L-arginine (A), L-glutamine (B), L-glutamate (C), or L-proline (D)
for 0, 0.5, 1.0, 2.0, and 4.0 h or supplemented with 2 mg LIF
antibody plus L-arginine, L-glutamine, L-glutamate or L-proline
(E). Ab, antibody; Arg, arginine; Gln, glutamine; Glu, glutamate;
Pro, proline.
(DOC)
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